医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

BioBytes™ – Redefining How We Care for Our Health One Byte at a Time

2021年01月25日 AM10:30
このエントリーをはてなブックマークに追加


 

DALLAS

IntelliCentrics (6819.HK), a healthcare technology platform company and innovator of the SEC³URE Ethos, SEC³URE Passport, Link & GO! and BioBytes™ serving North America, the United Kingdom and China, all on an integrated, end-to-end technology platform, announces the latest expansion of BioBytes™ innovations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210124005064/en/

“Whether at a local restaurant, grocery store, place of worship, or sports arena, people need to know each venue’s COVID Plan in order to feel safe when gathering in groups,” said Michael Sheehan, CEO of IntelliCentrics. “Hanging a sign on the door that says ‘masks are required’ isn’t enough anymore. So, we decided to take the same technology our hospital customers use to manage their COVID Plan and make it work anywhere people gather,” continued Sheehan.

The IntelliCentrics technology platform currently hosts over 11,000 locations of care, managing regulatory compliance for doctors, nurses, technicians and vendor representatives across North America, the United Kingdom and China. With the addition of BioBytes™, IntelliCentrics has successfully integrated the supply side of healthcare with the consumer side of healthcare in a highly innovative manner. The result is better data delivered significantly faster, massively lowering costs, and increasing quality for each stakeholder across the entire continuum of care.

“For an interior design firm, success depends on frequent in-person collaboration to build a trusted relationship with each client so we can deliver unique and highly personal spaces. The BioBytes™ app makes this possible by demonstrating to our clients the exact steps our firm takes to safeguard their personal safety,” said Traci Connell of Traci Connell Interiors. “And we have discovered BioBytes™ is appreciated by our suppliers just as much as our clients,” continued Connell.

Sheehan is equally excited about how BioBytes helps families remain safe. “Using the BioBytes™ app to communicate the family COVID Plan to all individuals entering the home, such as delivery personnel or gathering for a sporting event, ensures the home remains the safest place of all.”

“BioBytes™ is an exciting leap forward. By using the same app to create trusted interactions at home as well as at work, BioBytes™ is the best first step in our return to normal,” said Sheehan.

About Traci Connell Interiors

Traci Connell Interiors is an award-winning interior design firm that offers architectural and luxury interior design services. Known nationally for combining modern clean lines and classic styles, Traci and her talented team make every project unique to each client, using a collaborative approach to deliver high-end, durable, dynamic designs. With a combination of experience, artistry and passion, the Traci Connell team collaborates closely with you to bring your vision to life. www.traciconnellinteriors.com

About IntelliCentrics

With a mission to use trust to make high-quality healthcare as accessible as a good cup of coffee, IntelliCentrics created the SEC3URE Ethos. Built on three core principles – transparency, neutrality, and independence, the SEC3URE Ethos is relied on by more than 11,000 locations of care worldwide to ensure mutual trust between patients, doctors, vendor representatives and healthcare companies. To learn more about the world’s largest trusted healthcare technology platform, visit www.intellicentrics.com. To receive further information about BioBytes™, visit www.biobytes.net. IntelliCentrics is publicly traded on The Stock Exchange of Hong Kong Limited under the stock code 6819.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210124005064/en/

CONTACT

Jennifer Xia

972- 316-6523

jxia@intellicentrics.com

Related Posts Plugin for WordPress, Blogger...
TimeLine:

同じカテゴリーの記事 

  • ERS Genomicsと日本エスエルシーがCRISPR/Cas9ライセンス契約に署名
  • Mirum Pharmaceuticals and GC Pharma Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat for Rare Liver Diseases in South Korea
  • Dr. Revati Shreeniwas Joins ImmunoMet Therapeutics as Chief Medical Officer
  • Adagio Therapeutics Partners with Biocon Biologics to Bring Potent and Broadly Neutralizing COVID-19 Antibody Treatment to Patients in India and Select Emerging Markets
  • Twist Bioscience社がMOLCURE社の人工知能技術を導入し、抗体医薬品の探索を強化